Pathological-like assembly of tau induced by a paired helical filament core expressed at the plasma membrane

Journal of Alzheimer's Disease

Volumn 18, Issue 4, 2009, Pages 919-933

  Campos Peña, Victoria ^a,b   Tapia Ramírez, José ^a   Sánchez Torres, Carmen ^a   Meraz Rios, Marco Antonio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Alzheimer's disease; Membrane localization; Paired helical filaments; Tau aggregation; pleated sheet

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHIMERIC PROTEIN; COMPLEMENTARY DNA; HYDROGEN PEROXIDE; OKADAIC ACID; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BETA SHEET; CELL MEMBRANE; CELL STRAIN COS7; CHIMERA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOELECTRON MICROSCOPY; NEUROFIBRILLARY TANGLE; NONHUMAN; PAIRED HELICAL FILAMENT; POLYMERASE CHAIN REACTION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 74949127097     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1198     Document Type: Article

References (65)

1. Selkoe DJ (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271, 13-15.
2. Selkoe DJ (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8, 447-453.
3. Haass C, DeStrooper B (1999) The presenilins in Alzheimer's disease - proteolysis holds the key. Science 286, 916-919.
4. Li YM, Lai MT, XuM, Huang Q, DiMuzio-Mower J, Sardana MK, Shi XP, Yin KC, Shafer JA, Gardell SJ (2000) Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 97, 6138-6143.
5. Brion JP, Passareiro E, Nũnez J, Flament-Durand J (1985) Immunological detection of tau protein in neurofibrillary tangles of Alzheimer's disease. Arch Biol 95, 229-235. (Pubitemid 15000733)
6. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084-6089.
7. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein Tau (Tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83, 4913-4917.
8. Kosik KS, Joachim CL, Selkoe DJ (1986) Microtubuleassociated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 83, 4044-4048.
9. Wischik CM, Novak M, Thøgersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A (1988) Isolation of a fragment of Tau derived from the core of the paired helical filament of Alzheimer's disease. Proc Natl Acad Sci USA 85, 4506-4510.
10. Mena R EP, Perez-Olvera O,Wischik CM. (1995) Monitoring pathological assembly of tau and beta-amyloid proteins in Alzheimer's disease. Acta Neuropathol (Berl) 89, 50-56.
11. Mena R, Edwards PC, Harrington CR, Mukaetova-Ladinska EB, Wischik CM (1996) Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol (Berl) 91, 633-641.
12. Uchihara T, Nakamura A, Yamazaki M, Mori O (2000) Taupositive neurons in corticobasal degeneration and Alzheimer's disease - distinction by thiazin red and silver impregnations. Acta Neuropathol (Berl) 100, 385-389.
13. Uchihara T, Nakamura A, Yamazaki M, Mori O (2001) Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol (Berl) 101, 535-539. (Pubitemid 32684750)
14. Uchihara T NA, Yamazaki M, Mori O, Ikeda K, Tsuchiya K (2001) Different conformation of neuronal tau deposits distinguished by double immunofluorescence with AT8 and thiazin red combined with Gallyas method. Acta Neuropathol 102, 462-466.
15. Novak M, Kabat J, Wischik CM (1993) Molecular characterization of the minimal protease resistant Tau unit of the Alzheimer's disease paired helical filament. EMBO J 12, 365-370.
16. Novak M (1994) Truncated tau protein as a new marker for Alzheimer's disease. Acta Viroĺogica 38, 173-189.
17. Bondareff W, Wischik CM, Novak M, Amos WB, Klug A, Roth M (1990) Molecular analysis of neurofibrillary degeneration in Alzheimer's disease: an immunohistochemical study. Am J Pathol 137, 711-723.
18. Hrnkova M, Zilka N, Minichova Z, Koson P, Novak M (2007) Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats. Brain Res 1130, 206-213.
19. Koson P, Zilka N,Kovac A,Kovacech B,Korenova M, Filipcik P, Novak M (2008) Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. Eur J Neurosci 28, 239-246.
20. Fasulo L, Ovecka M, Kabat J, Bradbury A, Novak M, Cattaneo A (1996) Overexpression of Alzheimer's PHF core Tau fragments: implications for the tau truncation hypothesis. Alzheimer Res 2, 195-200.
21. Fasulo L, Visintin M, Novak M, Cattaneo A (1998) Tau truncation in Alzheimer disease: expression of a fragment encompassing PHF core Tau induces apoptosis in COS cells. Alzheimers Rep 1, 25-32.
22. Wischik CM, Edwards PC, Lai RY, Roth M, Harrington CR (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci USA 93, 11213-11218.
23. Novak M, Wischik CM, Edwards P, Pannell R, Milstein C (1989) Characterisation of the first monoclonal antibody against the pronase resistant core of the Alzheimer PHF. Prog Clin Biol Res 317, 755-761.
24. Farrar MA, Fernandez-Luna J, Schreiber RD (1991) Identification of two regions within the cytoplasmic domain of the human interferon-gamma receptor required for function. J Biol Chem 266, 19626-19635.
25. Perez RG, Squazzo SL, Koo EH (1996) Enhanced release of amyloid beta-protein from codon 670/671 Swedish mutant beta-amyloid precursor protein occurs in both secretory and endocytic pathways. J Biol Chem 271, 9100-9107.
26. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 56, 15-20.
27. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161, 1869-1879.
28. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189, 167-169.
29. Ṕerez M, Herńandez F, Ǵomez-Ramos A, Smith M, Perry G, Avila J (2002) Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur J Biochem 269, 1484-1489.
30. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519.
31. Ṕerez M, Cuadros R, Smith MA, Perry G, Avila J (2000) Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2- nonenal. FEBS Lett 486, 270-274.
32. Thurston VC, Zinkowski RP, Binder LI (1996) Tau as a nucleolar protein in human no neural cells in vitro and in vivo. Chromosoma 105, 20-30.
33. Cross DC, Mũnoz JP, Herńandez P, Maccioni RB (2000) Nuclear and cytoplasmic tau proteins from human no neuronal cells share common structural and functional features with brain tau. J Cell Biochem 78, 305-317.
34. Sj̈oberg MK, Shestakova E, Mansuroglu Z, Maccioni RB, Bonnefoy E (2006) Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization. J Cell Sci 119, 2025-2034.
35. Kimberly WT, Zheng JB, Gúenette SY, Selkoe DJ (2001) The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notchlike manner. J Biol Chem 276, 40288-40292.
36. Cao X, S̈udhof TC (2004) Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem 279, 24601-24611.
37. Nakaya T, Suzuki T (2006) Role of APP phosphorylation in FE65-dependent gene transactivation mediated by AICD. Genes Cells 11, 633-645.
38. Ferreira A, Lu Q, Orecchio L, Kosik KS (1997) Selective phosphorylation of adult Tau isoforms in mature hippocampal neurons exposed to fibrillar Abeta. Mol Cell Neurosci 9, 220-234.
39. Ryder J, Su Y, Liu F, Li B, Zhou Y, Ni B (2003) Divergent roles of GSK3 and Cdk5 In APP processing. Biochem Biophys Res Commun 312, 922-929.
40. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59, 214-225.
41. Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer's disease. J Neurochem. 104, 1433-1439.
42. Hernandez P, Lee G, Sjoberg M, Maccioni RB (2009) Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts. J Alzheimers Dis 16, 149-156.
43. Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS (1995) The toxicity in vitro of β-amyloid protein. Biochem J 311, 1-16.
44. Saito T, Kijima H, Kiuchi Y, Isobe Y, Fukushima K (2001) Beta-amyloid induces caspase-dependent early neurotoxic change in PC12 cells: correlation with H2O2 neurotoxicity. Neurosci Lett 305, 61-64.
45. Haas J, Storch-Hagenlocher B, Biessmann A, Wildemann B (2002) Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with betaamyloid 1-42 in vitro. Neurosci Lett 322, 121-125.
46. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloidbeta in Alzheimer's disease. Nat Rev Neurosci 7, 499-509.
47. Oster-Granite ML, McPhie DL, Greenan J, Neve RL (1996) Age-dependent neuronal and synaptic degeneration in mice transgenic for the C-terminus of the amyloid precursor protein. J Neurosci 16, 6732-6741.
48. Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA (1986) Identification of cDNA clones for the Tau human microtubuleassociated protein tau a chromosomal localization of the genes for Tau and microtubule-associated protein 2. Mol Brain Res 1, 271-280.
49. Berger-Sweeney J, McPhie DL, Arters JA, Greenan J, Oster- Granite ML, Neve RL (1999) Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Brain Res Mol Brain Res 66, 150-162.
50. Sergeant N, David JP, Champain D, Ghestem A, Wattez A, Delacourte A (2002) Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages in Alzheimer's disease. J Neurochem 81, 663-672.
51. Giaccone G, Pedrotti B, Migheli A, Verga L, Perez J, Racagni G, Smith MA, Perry G, De Gioia L, Selvaggini C, Salmona M, Ghiso J, Frangione B, Islam K, Bugiani O, Tagliavini F (1996) βAPP and tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease.AmJ Pathol 148, 79-87.
52. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99, 6364-6369.
53. Park SY, Ferreira A (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25, 5365-5375.
54. Bloom GS, Ren K, Glabe CG (2005) Cultured cell and transgenic mouse models for tau pathology linked to beta-amyloid. Biochim Biophys Acta 739, 116-124.
55. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98, 6923-6928.
56. Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2, 783-787.
57. Mena R, Robitaille Y, Cuello AC (1992) New patterns of intraneuronal accumulation of the microtubular binding domain of tau in granulovacuolar degeneration. J Geriatr Psychiatry Neurol 5, 132-141.
58. Bondareff W,Wischik CM, Novak M, Roth M(1991) Sequestration of tau by granulovacuolar degeneration in Alzheimer disease. Am J Pathol 139, 641-647.
59. Schneider A, Biernat J, Von Bergen M, Mandelkow E, Mandelkow EM (1999) Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38, 3549-3558.
60. Hall GF, Yao J, Lee G (1997) Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ. Proc Natl Acad Sci USA 94, 4733-4738.
61. Hall GF, Chu B, Lee G, Yao J (2000) Human tau induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease. J Cell Sci 113, 1373-1387.
62. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100, 10032-10037.
63. Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E, Novak M (2006) Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 580, 3582-3588.
64. Ugolini G, Cattaneo A, Novak M (1997) Co-localization of truncated tau and DNA fragmentation in Alzheimer disease neurons. Neuroreport 17, 3709-3712.
65. Canu N, Dus L, Barbato C, Ciotti MT, Brancolini C, Rinaldi AM, Novak M, Cattaneo A, Bradbury A, Calissano P (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci 18, 7061-7074. (Pubitemid 28425794)